T1 Condition 856 858 VM
T2 Level 303 320 endothelial cells
T3 Organism 946 957 Nicotimamid
T4 Gene 644 648 gene
T5 Intervention 1786 1796 neoplastic
T6 Condition 1821 1833 malignancies
T7 Condition 1000 1002 VM
T8 Biomarker 1280 1301 biologically-relevant
T9 Level 1461 1465 Cell
T10 Organism 138 146 melanoma
T11 Biomarker 1340 1352 nicotinamide
T12 Biomarker 715 727 Nicotinamide
T14 Condition 1624 1626 VM
T15 Condition 711 713 VM
T16 Condition 1180 1182 VM
T17 Level 1377 1390 melanoma cell
T18 Biomarker 578 583 amide
T19 Organism 348 356 melanoma
T20 Gene 1125 1136 VE-Cadherin
T22 Organism 138 155 melanoma patients
T23 Gene 1094 1123 vascular endothelial cadherin
T24 Biomarker 1541 1553 nicotinamide
T25 Biomarker 1056 1068 nicotinamide
T26 Biomarker 1347 1352 amide
T27 Level 47 93 vascular channels composed only of tumor cells
T28 Condition 1624 1636 VM and tumor
T29 Level 503 510 lesions
T30 Biomarker 571 583 nicotinamide
T31 Level 682 690 cellular
T32 Biomarker 615 621 niacin
T33 Condition 382 384 VM
T34 Level 426 448 human melanoma lesions
T35 Protein 1056 1075 nicotinamide-driven
T38 Gene 1247 1252 genes
T40 Level 470 483 cell cultures
T41 Organism 1377 1385 melanoma
T42 Intervention 516 521 tubes
T43 Gene 1247 1251 gene
T44 Condition 22 24 VM
T45 Gene 603 613 vitamin B3
T48 Biomarker 589 594 amide
T49 Condition 1660 1662 VM
T50 Organism 432 440 melanoma
T51 Condition 767 769 VM
T52 Biomarker 984 996 nicotinamide
